Opinion

Brown v. XGen Pharmaceuticals DJB, Inc.

Court
District Court, E.D. New York
Filed
Dec 4, 2023
Cited by
0 cases
Authority
More cited than 26.8%

“Where ‘the forum selected is not plaintiff’s home forum or the place where the operative facts of the action occurred . . . this diminishes the weight assigned to this factor.’”

How later courts described this case

  • “Where ‘the forum selected is not plaintiff’s home forum or the place where the operative facts of the action occurred . . . this diminishes the weight assigned to this factor.’”
  • “There is no indication from the parties that such witnesses would be subject to the process of this Court to compel their attendance at a trial conducted in this district.” (internal citation omitted)

Written by the judges who cited it.

The opinion

UNITED STATES DISTRICT COURT

EASTERN DISTRICT OF NEW YORK

----------------------------------------------------------------x

DEBRA BROWN,

Plaintiffs,

-against- ORDER

22-CV-7294-NGG-SJB

XGEN PHARMACEUTICALS DJB, Inc.,

Defendant.

----------------------------------------------------------------x

BULSARA, United States Magistrate Judge:

Defendant XGEN Pharmaceuticals DJB, Inc. (“XGEN”) has filed a motion to

transfer this civil rights action, brought by Plaintiff Debra Brown (“Brown”), to the

Western District of New York. For the reasons explained below, the motion is granted.

The pertinent facts are as follows: Brown alleges that XGEN unlawfully

terminated her employment due to her disability and failed to give her a reasonable

accommodation, in violation of the Americans with Disabilities Act (“ADA”) and state

and local human rights laws. (Compl., Dkt. No. 1 ¶ 1). Brown allegedly worked for

XGEN for about six years. (Id. ¶ 21, 44). Brown lives in Chemung County, (Id. ¶ 8), and

XGEN is located and headquartered there. (Decl. of J. Robin Liles in Supp. of XGEN

Pharmaceuticals DJB, Inc.’s Mot. to Transfer Venue dated June 7, 2023 (“Liles Decl.”),

Dkt. No. 23-4 ¶ 5). Chemung County is in the Western District of New York.

A threshold question is whether venue was first proper in this District. “A civil

action may be brought” in a district in which either “any defendant resides, if all

defendants are residents” of New York or “a substantial part of the events or omissions

giving rise to the claim occurred.” 28 U.S.C. § 1391(b)(1)–(2).

Brown’s opposition brief states, in essence, that XGEN is a resident of the

Eastern District because the Secretary of State’s website for the corporation gives a Long

Island address. (Pl.’s Mem. of Law in Opp’n to Def.’s Mot. to Transfer Venue dated June

28, 2023 (“Pl.’s Mem. of Law”), Dkt. No. 23-7 at 1–2); (June 1, 2023 N.Y. Department of

State Division of Corps. Entity Info. for XGEN Pharmaceuticals DJB, Inc., attached as

Ex. A to Liles Decl., Dkt. No. 23-5). XGEN states that the designation of a Long Island

address was in error because that location is the home of the company’s Chief Executive

Officer. (Liles Decl. ¶ 5). Section 1391(d) (“Residency of corporation in States with

multiple districts”)—which both parties fail to address—provides the straightforward

answer that the case was initially brought in a correct district. 14D Alan Wright &

Arthur R. Miller, Federal Practice and Procedure § 3811.1 (4th ed. 2023) (“The ‘multiple

district’ provision of Section 1391(d) addresses how personal jurisdiction is assessed in

states that have multiple districts. It requires the court to assess the entity's contacts

with a district as though that district [were] . . . a separate state. If that test is satisfied

with regard to more than one district in the state, the corporation resides in each such

district.”). For states like New York, with multiple federal districts, a corporation is

deemed to “reside in any district in that State within which its contacts would be

sufficient to subject it to personal jurisdiction if that district were a separate State.” 28

U.S.C. § 1391(d). Even if XGEN’s headquarters and sole office location are in the

Western District, it has not argued that its contacts with the Eastern District are so

insubstantial or nonexistent that it would not be subject to personal jurisdiction here if

this District were its own state. It repeatedly repeats the refrain that it is a resident of

the Western District only. But for corporations, section 1391(d) disposes of the concept

of residence in a single district. 14D Wright & Miller et al., supra at 2 (“Because an

entity defendant resides where the company is subject to personal jurisdiction,

corporations can reside in more than one district simultaneously.”). And by force of that

provision, XGEN “resides” not only in the Western District, but also here.

That venue was properly lodged in the first instance does not resolve whether the

case should remain here. On that score, it is Brown’s papers that fall short. “A district

court may exercise its discretion to transfer venue ‘for the convenience of parties and

witnesses, in the interest of justice.’” N.Y. Marine & Gen. Ins. Co. v. Lafarge N. Am.,

Inc., 599 F.3d 102, 112 (2d Cir. 2010) (quoting 28 U.S.C. § 1404(a)). “Among the factors

to be considered in determining whether to grant a motion to transfer venue ‘are, inter

alia: (1) the plaintiff's choice of forum, (2) the convenience of witnesses, (3) the location

of relevant documents and relative ease of access to sources of proof, (4) the

convenience of parties, (5) the locus of operative facts, (6) the availability of process to

compel the attendance of unwilling witnesses, and (7) the relative means of the parties.’”

Id. (quoting D.H. Blair & Co., Inc. v. Gottdiener, 462 F.3d 95, 106–7 (2d Cir. 2006)).

“[T]he party requesting transfer carries the ‘burden of making out a strong case for

transfer.’” Id. at 114 (quoting Filmline (Cross-Country) Prods., Inc. v. United Artists

Corp., 865 F.2d 513, 521 (2d Cir. 1989)) (noting district courts are correct in finding that

clear and convincing evidence is necessary to demonstrate transfer is appropriate).

XGEN prevails on the most significant of these factors. As to the first, plaintiff’s

choice of forum, “courts have noted that the weight given to this factor is diminished

where (1) the operative facts have ‘little or no connection’ with the forum chosen by the

plaintiff[.]” EasyWeb Innovations, LLC v. Facebook, Inc., 888 F. Supp. 2d 342, 348

(E.D.N.Y. 2012) (collecting cases); see also Dickerson v. Novartis Corp., 315 F.R.D. 18,

32 (S.D.N.Y. 2016) (“Where ‘the forum selected is not plaintiff’s home forum or the

place where the operative facts of the action occurred . . . this diminishes the weight

assigned to this factor.’”) (quoting McGraw-Hill Cos., Inc., v. Charles Jones, et al., No.

12-CV-7085, 2014 WL 988607, at *7 (S.D.N.Y. Mar. 12, 2014)) (c0llecting cases).

Although Brown has chosen to file here, her election carries little weight given that she

resides in the Western District and worked there exclusively. And while her brief and

declaration assert that “a substantial number of transactions” and “business operations”

took place in the Eastern District, (June 2023 Decl. of Debra Brown in Opp’n to Def.’s

Mot. to Transfer Venue (“Brown Decl.”), Dkt. No. 23-10 ¶¶ 7, 9), these are conclusory,

detail-less allegations. They simply lack any credibility without any details and in the

face of the proof and details provided by XGEN. Though Brown alleges she worked in

the accounting department and “all the main accounting business was conducted on

Long Island,” (Id. ¶ 6), she herself did so from the Western District, and never alleges

travelling or actually working in the Eastern District itself. (Reply Decl. of J. Robin Liles

in Further Supp. of Def. XGEN Pharmaceuticals DJB, Inc.’s Mot. to Transfer Venue

dated July 12, 2023 (“Liles Reply Decl.”), Dkt. No. 23-14 ¶¶ 12, 15). The fact that XGEN

was founded in Long Island, (Brown Decl. ¶ 8), does nothing to counter the proof that

XGEN is currently headquartered elsewhere, and has no office location other than in the

Western District of New York. (Liles Reply Decl. ¶ 3).

At best, her proof amounts to showing that one Executive Officer, albeit an

important one, worked from Long Island. (Id. ¶ 4.) But she does not allege that she

worked with the CEO, if at all, and does not dispute that the Long Island address is only

the CEO’s home, not a XGEN office. (Id. ¶¶ 4, 11–13). Finally, Brown was terminated

from employment in the Western District, and the decision to terminate her was made

there (as was the alleged decision to deny her a reasonable accommodation). (Id. ¶¶ 12,

16). Given the overwhelming set of facts and events taking place elsewhere, Brown’s

choice of forum is entitled to no weight. In contrast, the strong connection of these

events to the Western District suggest transfer is appropriate there. See e.g., Dickerson,

315 F.R.D. at 30 (“Here, the Court finds that the operative events giving rise to Plaintiff’s

allegations occurred in the Northern District of Texas—that is where she was employed;

where she complained of pay discrimination; where she was denied promotions and pay

raises; where she was given negative performance evaluations; where she took medical

leave; where she was investigated; and where she was ultimately terminated.”).

As to the second factor, witness convenience, this too favors transfer. “The

convenience of the witnesses is probably the single most important factor in the transfer

analysis.” Neil Bros. Ltd. v. World Wide Lines, Inc., 425 F. Supp. 2d 325, 329 (E.D.N.Y.

2006) (collecting cases). It appears that all the witnesses reside and work in the

Western District. Brown and most of the XGEN witnesses reside there. (Def.’s Mem. of

Law in Supp. of Def. XGEN Pharmaceuticals DJB, Inc.’s Mot. To Transfer Venue dated

June 8, 2023 (“Def.’s Mem. of Law”), Dkt. No. 23-6 at 7). All Brown can muster in

response is that XGEN’s brief fails to identify these individuals and only refers to them

as a group. (Pl.’s Mem. of Law at 4). But Brown herself identified them in her Rule

26(a) initial disclosures, (Pl.’s Rule 26(a) Disclosures, attached as Ex. 1 to Reply Decl. of

Amanda A. Tersigni in Further Supp. of Def. XGEN Pharmaceuticals DJB, Inc.’s Mot. to

Transfer Venue dated July 13, 2023, Dkt. No. 23-13 at 2–3), and those individuals are

indisputably tied to the Western District and have no connection here.

The remaining factors also favor transfer. While the location of documents is

perhaps less relevant in an era of largely electronic discovery, see Am. Steamship

Owners Mut. Prot. & Indem. Ass'n, Inc. v. Lafarge N. Am., Inc., 474 F. Supp. 2d 474,

484 (S.D.N.Y. 2007), aff'd sub nom. N.Y Marine & Gen. Ins. Co. v. Lafarge N. Am., Inc.,

599 F.3d 102 (2d Cir. 2010), Brown does not, and cannot credibly, dispute that the

documents are located at XGEN’s headquarters (or her residence), again in the Western

District. For the same reasons that Brown’s choice of forum is entitled to no deference,

the factor regarding the locus of operative facts strongly favors transfer. Supra at 3–5.

The subpoena and process factor favors transfer, because although the non-party

witnesses may be executives (and supervisors), they are not all XGEN officers. And as

such, they are subject to the 100-mile bulge rule under Rule 45, meaning that they can

only be forced to testify (at trial or for a deposition) in the Western District. Assuming

XGEN does not produce the witnesses voluntarily or the witnesses no longer work for

the company, they cannot be subpoenaed to appear in the Eastern District. See Fed. R.

Civ. P. 45(c)(1). It is impossible to see how Brown could prosecute her case without the

testimony of these witnesses, who again were identified in the Rule 26(a) disclosures

and who took part in the allegedly unlawful discrimination. Frasca v. Yaw, 787 F. Supp.

327, 332 (E.D.N.Y. 1992) (“There is no indication from the parties that such witnesses

would be subject to the process of this Court to compel their attendance at a trial

conducted in this district.” (internal citation omitted)); cf. Kaufman v. Salesforce.com,

No. 20-CV-06879, 2021 WL 1687378, at *10 (S.D.N.Y. Apr. 29, 2021) (“To Salesforce's

point, the prior art witnesses and Salesforce's former employees in the San Francisco

Bay Area can be compelled to testify at trial by the District Court for the Northern

District of California, and not by this Court.”), aff’d, No. 20-CV-6879, 2021 WL 2269552

(June 3, 2021). And as to the final factor, Brown agrees that this factor is neutral. (Pl.’s

Mem. of Law at 8).

Given that all the factors, save one, favor transfer, the Clerk of Court is directed to

transfer this case to the Western District of New York. Because transfer is a non-

dispositive action, no report and recommendation is necessary, and the Clerk may

effectuate the transfer absent any action by a District Judge. Alexander v. Comm’r of

Soc. Sec., No. 23-CV-6964, 2023 WL 6125634, at *3 (S.D.N.Y. Sept. 19, 2023) (collecting

cases). To the extent, however, that Brown objects to the action, she must file objections

within 14 days. See Fed. R. Civ. P. 72(a) (noting objections to non-dispositive orders are

subject to clear error review). As such, the Clerk should transfer the case only upon the

expiration of the 14-day period or if objections are filed, upon the District Judge’s

resolution of such objections, whichever is later.

SO ORDERED.

/_s/_ _Sa_n_k_e_t _J_. B_u_l_sa_r_a_ _ D_e_c_em__b_er 4, 2023

SANKET J. BULSARA

United States Magistrate Judge

Brooklyn, New York

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.